product summary
Loading...
company name :
HUABIO
product type :
antibody
product name :
CD25 / IL-2 Receptor alpha
catalog :
HA601530F
quantity :
100T
price :
219.00 USD
clonality :
monoclonal
host :
mouse
conjugate :
APC
clone name :
PSH14-46
reactivity :
human
application :
flow cytometry
more info or order :
image
image 1 :

Flow cytometric analysis of human peripheral blood cells labelling CD25 / IL-2 Receptor alpha (HA601530F, APC) and CD4 (HA600119F, FITC).
Cells were washed twice with cold PBS and resuspend. Then incubated for 1 hour at +4℃ with CD25 / IL-2 Receptor alpha (HA601530F, APC, 1/500) compared with Mouse IgG Isotype Control (APC, 1/1,000).
product information
SKU :
HA601530F
Target name :
CD25 / IL-2 Receptor alpha
Species reactivity :
Human
Applications :
FC
Conjugate :
APC
Uniprot id :
P01589>SwissProt: P01589 Human
Host :
Mouse
Clone number :
PSH14-46
Isotype :
IgG1
Size :
100T
List Price :
219.00 USD
Storage Buffer :
Supplied in phosphate-buffered solution, pH 7.2, containing 0.2% ProClean 950 and BSA.
Form :
Liquid
Storage Instruction :
Store at 2℃ to 8℃. Avoid repeated freeze / thaw cycles.
Purity :
Protein A affinity purified.
Product type :
Recombinant Mouse monoclonal Antibody
Positive control :
Human peripheral blood cells.
Molecular wt :
Predicted band size: 31 kDa
Subcellular location :
Membrane
Concentration :
/
Recommended dilutions :
FC: 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
more info or order :
company information

HUABIO
Founded in 2007, HUABIO is dedicated to developing high-quality antibodies that advance innovation. We are passionate about the accuracy, efficiency, and consistency of our products. That is why we have invested in new production platforms, like recombinant rabbit monoclonals, alpaca nanobodies, and adopted aggressive QA standards to deliver cutting-edge antibodies with uncompromised quality.
We hope to see you at your next discovery!
We hope to see you at your next discovery!
related products
browse more products
questions and comments
